kabutan

TAKARA BIO INC.(4974) Summary

4974
TSE Prime
TAKARA BIO INC.
1,146
JPY
0
(0.00%)
Mar 13, 3:30 pm JST
7.18
USD
Mar 13, 2:30 am EDT
Result
PTS
outside of trading hours
1,146.2
Mar 13, 9:59 pm JST
Summary Chart Historical News Financial Result
PER
PBR
1.37
Yield
ー%
Margin Trading Ratio
10.32
Stock Price
Mar 13, 2026
Opening Mar 13, 9:00 am
1,146 JPY 7.19 USD
Previous Close Mar 12
1,146 JPY 7.20 USD
High Mar 13, 9:00 am
1,147 JPY 7.21 USD
Low Mar 13, 9:00 am
1,146 JPY 7.17 USD
Volume
645,800
Trading Value
0.74B JPY 4.64M USD
VWAP
1146.19 JPY 7.19 USD
Minimum Trading Value
114,600 JPY 718 USD
Market Cap
0.14T JPY 0.87B USD
Number of Trades
453
Liquidity & Number of Trades
As of Mar 13, 2026
Liquidity
Slightly High
1-Year Average
580
1-Year High Aug 21, 2025
6,306
Margin Trading
Date Short Interest Long Margin Positions Ratio
Mar 6, 2026 12,000 140,600 11.72
Feb 27, 2026 143,900 162,800 1.13
Feb 20, 2026 216,600 274,600 1.27
Feb 13, 2026 243,300 569,900 2.34
Feb 6, 2026 209,500 608,600 2.91
Company Profile
TAKARA BIO INC. is a leading supplier of reagents and equipment for genetic research, with a strong focus on iPS cells and regenerative medicine. The company also offers contract services.
Sector
Chemicals
TAKARA BIO INC. operates businesses based on biotechnology, utilizing genetic engineering and cell engineering technologies. In its core reagents and equipment business, the company provides products and services for gene and cell analysis. In the contract business, TAKARA BIO INC. offers CDMO services including genetic analysis, testing, and regenerative medicine product-related contract services. In the gene therapy business, the company develops, manufactures, and sells manufacturing aids used in gene therapy drug production, and is advancing clinical development of gene therapy drugs using proprietary technologies.